![PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression - ScienceDirect PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352289520300126-gr1.jpg)
PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression - ScienceDirect
![Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation - Karout - 2016 - Journal of Neurochemistry - Wiley Online Library Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation - Karout - 2016 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5736ae6f-8df8-4098-9f17-88a7ab64a1c5/jnc13693-fig-0008-m.png)
Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation - Karout - 2016 - Journal of Neurochemistry - Wiley Online Library
![Structures of natural neuroactive steroid, allopregnanolone, and its... | Download Scientific Diagram Structures of natural neuroactive steroid, allopregnanolone, and its... | Download Scientific Diagram](https://www.researchgate.net/publication/230091489/figure/fig1/AS:738904831430657@1553180048041/Structures-of-natural-neuroactive-steroid-allopregnanolone-and-its-synthetic-analog.png)
Structures of natural neuroactive steroid, allopregnanolone, and its... | Download Scientific Diagram
Development and Screening of Water-Soluble Analogues of Progesterone and Allopregnanolone in Models of Brain Injury | Journal of Medicinal Chemistry
![Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection - ScienceDirect Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960076014002003-gr3.jpg)
Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection - ScienceDirect
![Biosynthesis of allopregnanolone and pregnenolone sulfate (PS) from... | Download Scientific Diagram Biosynthesis of allopregnanolone and pregnenolone sulfate (PS) from... | Download Scientific Diagram](https://www.researchgate.net/publication/225087011/figure/fig1/AS:271745781334029@1441800651423/Biosynthesis-of-allopregnanolone-and-pregnenolone-sulfate-PS-from-cholesterol-within.png)
Biosynthesis of allopregnanolone and pregnenolone sulfate (PS) from... | Download Scientific Diagram
![Frontiers | Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development Frontiers | Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development](https://www.frontiersin.org/files/MyHome%20Article%20Library/1140796/1140796_Thumb_400.jpg)
Frontiers | Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
![PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300 | Business Wire PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300 | Business Wire](https://mms.businesswire.com/media/20220613005870/en/1485412/5/LYT-300_POP_61422.jpg)
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300 | Business Wire
![PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders | Business Wire PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders | Business Wire](https://mms.businesswire.com/media/20230621618951/en/1396139/22/2022_Horizontal_transparent_white.jpg)